BioPharma, Devices & Diagnostics

A snapshot of life sciences M&A deals in the second quarter

Mega mergers continued to drive M&A deal value higher in the second quarter of the year, but the number of life sciences deals fell from the first quarter of the year, as well as from the same period last year.

By Arundhati Parmar on August 03, 2016
presented by

gene money

Mega mergers continued to drive M&A deal value higher in the second quarter of the year, but the number of life sciences deals fell from the first quarter of the year, as well as from the same period last year.

Here’s an infographic MedCity News created based on PwC’s Global Pharma & Life Sciences Deals Insights Q2 2016 Update.

Topics